StockData
Grace Therapeutics, Inc. logo

Grace Therapeutics, Inc. (GRCE) community

GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.81+0.00 (0.00%)

Close on Nov 13, 2026Market cap $38.08MP/E –Yield –

Community

Notes and questions about Grace Therapeutics from other investors

No posts about GRCE yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

See a number that looks wrong?